Details of the Drug

General Information of Drug (ID: DMHMUUM)

Drug Name

Valiloxybate

Synonyms

Valiloxibic acid; VALILOXYBATE; 4-((L-Valyl)oxy)butanoic acid; 238401-16-6; Valiloxybate [USAN]; XWL-008; XW10172; 9B8NWP8K91; L-Valine, 3-carboxypropyl ester; XW-10172; starbld0003028; VALILOXYBATE [INN]; UNII-9B8NWP8K91; SCHEMBL3730354; CHEMBL5095201; WHO 11367; AKOS040757642; MS-23099; HY-137429; CS-0138627; 4-[(2S)-2-amino-3-methylbutanoyl]oxybutanoic acid; 4-{[(2S)-2-amino-3-methylbutanoyl]oxy}butanoic acid

Indication

Disease Entry	ICD 11	Status	REF
Parkinson disease	8A00.0	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C9H17NO4
Canonical SMILES: CC(C)C(C(=O)OCCCC(=O)O)N
InChI: InChI=1S/C9H17NO4/c1-6(2)8(10)9(13)14-5-3-4-7(11)12/h6,8H,3-5,10H2,1-2H3,(H,11,12)/t8-/m0/s1
InChIKey: RMGPNQKZEPTAOC-QMMMGPOBSA-N

Cross-matching ID

PubChem CID: 54274194
TTD ID: DGK6R3

References

1	ClinicalTrials.gov (NCT05056194) A Double-blind, Randomized, Placebo-controlled, Parallel, Study to Assess the Efficacy and Safety of XW10172 MR for the Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease. U.S.National Institutes of Health.